Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yuko Yonezawa

Retrospective Study of Risk Factors Associated With Hepatic Dysfunction Induced by Daclatasvir/Asunaprevir

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

2018

English

Mechanism of Cell Cycle Arrest and Apoptosis Induction by Conjugated Eicosapentaenoic Acid, Which Is a Mammalian DNA Polymerase and Topoisomerase Inhibitor

International Journal of Oncology

Cancer Research

Oncology

2007

English

Related publications

Risk Factors for Hepatic Veno-Occlusive Disease Caused by Gynura Segetum: A Retrospective Study

English

Hepatic Impairment Induced by Scrub Typhus Is Associated With New Onset of Renal Dysfunction

English

Hemoglobin Decrease With Iron Deficiency Induced by Daclatasvir Plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b

PLoS ONE

Multidisciplinary

2016

English

A Study on Hepatic Dysfunction Associated With Rubella Infection

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases

Medicine

1991

English

Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir: TABLE 1

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2015

English

Correlation Between Efficacy of Daclatasvir/Asunaprevir Combination Therapy and HCV NS3/NS5A Resistance-Associated Variants Detected by the PCR-Invader Assay

Acta Hepatologica Japonica

Hepatology

2015

English

Potential Risk Factors for Nivolumab-Induced Thyroid Dysfunction

English

Changes in Serum LDL, PCSK9 and microRNA‑122 in Patients With Chronic HCV Infection Receiving Daclatasvir/Asunaprevir

English

Risk Factors and Mediators of the Vascular Dysfunction Associated With Hypertension in Pregnancy

Cardiovascular and Hematological Disorders - Drug Targets

Cardiovascular Medicine

Medicine

2010

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yuko Yonezawa

Retrospective Study of Risk Factors Associated With Hepatic Dysfunction Induced by Daclatasvir/Asunaprevir

Mechanism of Cell Cycle Arrest and Apoptosis Induction by Conjugated Eicosapentaenoic Acid, Which Is a Mammalian DNA Polymerase and Topoisomerase Inhibitor

Related publications

Risk Factors for Hepatic Veno-Occlusive Disease Caused by Gynura Segetum: A Retrospective Study

Hepatic Impairment Induced by Scrub Typhus Is Associated With New Onset of Renal Dysfunction

Hemoglobin Decrease With Iron Deficiency Induced by Daclatasvir Plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b

A Study on Hepatic Dysfunction Associated With Rubella Infection

Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir: TABLE 1

Correlation Between Efficacy of Daclatasvir/Asunaprevir Combination Therapy and HCV NS3/NS5A Resistance-Associated Variants Detected by the PCR-Invader Assay

Potential Risk Factors for Nivolumab-Induced Thyroid Dysfunction

Changes in Serum LDL, PCSK9 and microRNA‑122 in Patients With Chronic HCV Infection Receiving Daclatasvir/Asunaprevir

Risk Factors and Mediators of the Vascular Dysfunction Associated With Hypertension in Pregnancy